NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX)
Post# of 231
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will participate at the Diamond Equity Research Emerging Growth Invitational taking place virtually on Dec. 1, 2020. According to the update, Genprex’s executive vice president and COO, Michael Redman, will virtually deliver a company overview to investors followed by a guided question and answer session. Redman’s presentation is scheduled to begin at 11:30 a.m. ET on Dec. 1. Interested parties may visit https://www.nnw.fm/BjNia to register for the webinar. A live audio webcast and archive of the conference presentation will be available for a period of time using the registration link.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer